PDK1 mRNA expression is elevated in human hepatocellular carcinoma, and Lin28 regulates PDK1 mainly via a post‐transcriptional mechanism, suggesting a novel rationale for targeting PDK1 for cancer therapy.21 The gene discussed is LIN28A; the disease is hepatocellular carcinoma.